Â鶹ӳ»­

Â鶹ӳ»­ MD Anderson Cancer Center¡¯s Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD?Anderson experts. Current advances include a novel HER2-targeted bispecific antibody for several types of cancers, an immunotherapy and PARP-inhibitor combination that may benefit specific tumor molecular subtypes, a comprehensive look at the efficacy of eligibility criteria...

Â鶹ӳ»­ MD Anderson Cancer Center today announced that Eyal Gottlieb, Ph.D., has been named the institution¡¯s vice president for Research. Gottlieb, an accomplished scientist and leader, will join MD Anderson in January to uphold and expand the institution¡¯s research excellence.

In this role, Gottlieb will oversee laboratory science departments leading innovative discovery and translational research across a variety...